Zirwas, M., Draelos, Z., Dubois, J., Kircik, L. , Moore, A., Stein Gold, L., Alonso-Llamazares, J. , Bukhalo, M., Bruce, S., Eads, K., Green, L., Guenthner, S., Ferris, L., Forman, S., Kempers, S., Lain, E. , Lynde, C., Pariser, D., Pariser, D., Toth, D., Yamauchi, paul, Burnett, P. and Berk, D. 2021. A Randomized, Double-blind, Vehicle-Controlled Phase 2a Study Evaluating Once Daily Roflumilast Foam 0.3% in Patients With Moderate to Severe Seborrheic Dermatitis. SKIN The Journal of Cutaneous Medicine. 5, 6 (Nov. 2021), s94. DOI:https://doi.org/10.25251/skin.5.supp.94.